Fleming I - Search Results

1

The Consequences of Soluble Epoxide Hydrolase Deletion on Tumorigenesis and Metastasis in a Mouse Model of Breast Cancer.

Kesavan R, Frömel T, Zukunft S, Brüne B, Weigert A, Wittig I, Popp R, Fleming I. Kesavan R, et al. Among authors: fleming i. Int J Mol Sci. 2021 Jul 1;22(13):7120. doi: 10.3390/ijms22137120. Int J Mol Sci. 2021. PMID: 34281173 Free PMC article.

2

Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor.

Bauersachs J, Popp R, Hecker M, Sauer E, Fleming I, Busse R. Bauersachs J, et al. Among authors: fleming i. Circulation. 1996 Dec 15;94(12):3341-7. doi: 10.1161/01.cir.94.12.3341. Circulation. 1996. PMID: 8989149

3

A transferable, beta-naphthoflavone-inducible, hyperpolarizing factor is synthesized by native and cultured porcine coronary endothelial cells.

Popp R, Bauersachs J, Hecker M, Fleming I, Busse R. Popp R, et al. Among authors: fleming i. J Physiol. 1996 Dec 15;497 ( Pt 3)(Pt 3):699-709. doi: 10.1113/jphysiol.1996.sp021801. J Physiol. 1996. PMID: 9003555 Free PMC article.

4

Endothelium-derived hyperpolarizing factor, but not nitric oxide, is reversibly inhibited by brefeldin A.

Bauersachs J, Fleming I, Scholz D, Popp R, Busse R. Bauersachs J, et al. Among authors: fleming i. Hypertension. 1997 Dec;30(6):1598-605. doi: 10.1161/01.hyp.30.6.1598. Hypertension. 1997. PMID: 9403589

5

Nitric oxide and endothelium-derived hyperpolarizing factor: formation and interactions.

Bauersachs J, Popp R, Fleming I, Busse R. Bauersachs J, et al. Among authors: fleming i. Prostaglandins Leukot Essent Fatty Acids. 1997 Oct;57(4-5):439-46. doi: 10.1016/s0952-3278(97)90425-7. Prostaglandins Leukot Essent Fatty Acids. 1997. PMID: 9430393

6

Pulsatile stretch in coronary arteries elicits release of endothelium-derived hyperpolarizing factor: a modulator of arterial compliance.

Popp R, Fleming I, Busse R. Popp R, et al. Among authors: fleming i. Circ Res. 1998 Apr 6;82(6):696-703. doi: 10.1161/01.res.82.6.696. Circ Res. 1998. PMID: 9546378

7

Inhibition of the production of endothelium-derived hyperpolarizing factor by cannabinoid receptor agonists.

Fleming I, Schermer B, Popp R, Busse R. Fleming I, et al. Br J Pharmacol. 1999 Feb;126(4):949-60. doi: 10.1038/sj.bjp.0702381. Br J Pharmacol. 1999. PMID: 10193775 Free PMC article.

8

Cytochrome P450 2C is an EDHF synthase in coronary arteries.

Fisslthaler B, Popp R, Kiss L, Potente M, Harder DR, Fleming I, Busse R. Fisslthaler B, et al. Among authors: fleming i. Nature. 1999 Sep 30;401(6752):493-7. doi: 10.1038/46816. Nature. 1999. PMID: 10519554

9

Nifedipine increases cytochrome P4502C expression and endothelium-derived hyperpolarizing factor-mediated responses in coronary arteries.

Fisslthaler B, Hinsch N, Chataigneau T, Popp R, Kiss L, Busse R, Fleming I. Fisslthaler B, et al. Among authors: fleming i. Hypertension. 2000 Aug;36(2):270-5. doi: 10.1161/01.hyp.36.2.270. Hypertension. 2000. PMID: 10948089

10

The coronary endothelium-derived hyperpolarizing factor (EDHF) stimulates multiple signalling pathways and proliferation in vascular cells.

Fleming I, Fisslthaler B, Michaelis UR, Kiss L, Popp R, Busse R. Fleming I, et al. Pflugers Arch. 2001 Jul;442(4):511-8. doi: 10.1007/s004240100565. Pflugers Arch. 2001. PMID: 11510882

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

622 results

Search Page

Filters